GNRH1 and polycystic ovary syndrome: Conventional GnRHant protocols have been shown to be safer and more cost-effective for PCOS patients going through IVF/ICSI cycles than the standard long GnRH agonist protocol, with no negative clinical impact on IVF/ICSI outcomes, according to Kadoura et al. [81].